Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Leukemia

3,3',5-triiodothyroacetic acid has been researched along with Leukemia in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ALEXANDER, WD1
BISSET, SK1

Other Studies

1 other study available for 3,3',5-triiodothyroacetic acid and Leukemia

ArticleYear
Immediate effect of triiodothyroacetic acid on oxygen consumption of myeloid leukaemic leucocytes in vitro.
    Lancet (London, England), 1958, Dec-13, Volume: 2, Issue:7059

    Topics: Humans; In Vitro Techniques; Leukemia; Leukemia, Myeloid; Leukocytes; Metabolism; Oxygen Consumption

1958